Altice USA, Inc. (ATUS) Forms $18.33 Double Bottom; K2m Group Holdings (KTWO) Shorts Increased By 18.36%

Altice USA, Inc. (ATUS) formed double bottom with $17.59 target or 4.00% below today’s $18.33 share price. Altice USA, Inc. (ATUS) has $13.51 billion valuation. The stock increased 0.74% or $0.135 during the last trading session, reaching $18.325. About 57,088 shares traded. Altice USA, Inc. (NYSE:ATUS) has 0.00% since March 29, 2017 and is . It has underperformed by 11.55% the S&P500.

K2m Group Holdings Inc (NASDAQ:KTWO) had an increase of 18.36% in short interest. KTWO’s SI was 2.80M shares in March as released by FINRA. Its up 18.36% from 2.37M shares previously. With 242,900 avg volume, 12 days are for K2m Group Holdings Inc (NASDAQ:KTWO)’s short sellers to cover KTWO’s short positions. The SI to K2m Group Holdings Inc’s float is 6.68%. The stock decreased 0.43% or $0.08 during the last trading session, reaching $18.62. About 9,496 shares traded. K2M Group Holdings, Inc. (NASDAQ:KTWO) has declined 4.71% since March 29, 2017 and is downtrending. It has underperformed by 16.26% the S&P500.

Analysts await Altice USA, Inc. (NYSE:ATUS) to report earnings on May, 22.

Among 6 analysts covering Altice USA (NYSE:ATUS), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Altice USA has $38 highest and $25 lowest target. $31.25’s average target is 70.53% above currents $18.325 stock price. Altice USA had 7 analyst reports since June 23, 2017 according to SRatingsIntel. Pivotal Research initiated the shares of ATUS in report on Friday, June 23 with “Buy” rating. The firm earned “Neutral” rating on Friday, September 15 by Guggenheim. The firm has “Market Perform” rating given on Wednesday, July 26 by Wells Fargo. The firm earned “Buy” rating on Tuesday, November 7 by Goldman Sachs. RBC Capital Markets maintained it with “Outperform” rating and $35 target in Tuesday, November 14 report. Pivotal Research maintained the shares of ATUS in report on Wednesday, December 6 with “Buy” rating. The firm earned “Buy” rating on Friday, November 10 by Moffett Nathanson.

K2M Group Holdings, Inc., a medical device company, focuses on designing, developing, and commercializing spine and minimally invasive solutions in the United States and internationally. The company has market cap of $807.62 million. The firm provides implants, disposables, and instruments primarily to hospitals for use by spine surgeons to treat spinal pathologies, such as deformity, trauma, and tumor. It currently has negative earnings. The Company’s complex spine products include EVEREST, MESA, MESA 2, and DENALI deformity spinal systems; NILE alternative fixation systems; MESA rail deformity spinal systems; Cricket and Quicket deformity systems; CAPRI corpectomy cage systems; MESA small stature, rail small stature, and mini spinal systems; SERENGETI complex spine minimally invasive retractor systems; RAVINE complex spine lateral access systems; and SANTORINI corpectomy cage systems.